Progression from impaired glucose tolerance to type 2 diabetes in obese children and adolescents: a 3-6-year cohort study in southern Thailand

J Pediatr Endocrinol Metab. 2016 Nov 1;29(11):1267-1275. doi: 10.1515/jpem-2016-0195.

Abstract

Background: Childhood obesity is associated with abnormal glucose metabolism and type 2 diabetes mellitus (T2DM). This study evaluated the prevalence of abnormal glucose metabolism in asymptomatic obese children and adolescents, and determined the percentage of T2DM development after 3-6 years of follow-up.

Methods: During 2007-2013, 177 obese children and adolescents who had normal fasting plasma glucose (FPG<100 mg/dL) were given an oral glucose tolerance test (OGTT). The participants were classified into four groups: normal glucose tolerance (NGT), NGT-hyperinsulinemia (NGT-HI), impaired glucose tolerance (IGT), and diabetes mellitus (DM). Blood chemistries, including FPG, glycated hemoglobin, and lipid profiles, and liver function test were performed every 6-12 months or when the patient developed any symptom or sign indicative of diabetes.

Results: Glucose metabolism alterations were detected in 81.4% of the participants: 63.8% with NGT-HI, 15.3% with IGT, and 2.3% with T2DM. The median levels of homeostasis model assessment-insulin resistance (HOMA-IR) in patients with IGT (8.63) were significantly greater than those in the patients with NGT (4.04) (p<0.01). During the follow-up, 22 patients (14.4%) developed T2DM significantly more from the IGT group (nine of 33 cases, 27.3%) than the NGT-HI group (12 of 108 cases, 11.1%) (p=0.022). The predicting parameters for T2DM conversion were weight status, body mass index (BMI), FBG, fasting insulin, alanine transaminase (ALT) levels, and HOMA-IR.

Conclusions: Glucose metabolism alteration was commonly found among obese adolescents. Factors associated with T2DM development were greater weight status and the severity of insulin resistance as shown by higher HOMA-IR levels.

MeSH terms

  • Adolescent
  • Biomarkers / blood
  • Body Mass Index
  • Child
  • Cohort Studies
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / ethnology
  • Diabetes Mellitus, Type 2 / etiology*
  • Disease Progression
  • Female
  • Glucose Intolerance / complications
  • Glucose Intolerance / ethnology
  • Glucose Intolerance / metabolism
  • Glucose Intolerance / physiopathology*
  • Health Transition
  • Humans
  • Hyperinsulinism / complications
  • Hyperinsulinism / ethnology
  • Hyperinsulinism / metabolism
  • Hyperinsulinism / physiopathology*
  • Insulin Resistance* / ethnology
  • Longitudinal Studies
  • Male
  • Overweight / blood
  • Overweight / complications*
  • Overweight / ethnology
  • Pediatric Obesity / blood
  • Pediatric Obesity / complications*
  • Pediatric Obesity / ethnology
  • Prediabetic State / complications
  • Prediabetic State / ethnology
  • Prediabetic State / metabolism
  • Prediabetic State / physiopathology*
  • Prevalence
  • ROC Curve
  • Risk
  • Thailand / epidemiology

Substances

  • Biomarkers